Real-World Safety and Efficacy of 156 U – 195 U OnabotulinumtoxinA in Adults With Chronic Migraine: Results From the REPOSE Study.
Saved in:
| Title: | Real-World Safety and Efficacy of 156 U – 195 U OnabotulinumtoxinA in Adults With Chronic Migraine: Results From the REPOSE Study. |
|---|---|
| Authors: | Ahmed, Fayyaz1 (AUTHOR) fayyaz.ahmed@nhs.net, Gaul, Charly2 (AUTHOR), Kollewe, Katja3 (AUTHOR), Singh, Ritu C.4 (AUTHOR), Sommer, Katherine5 (AUTHOR) |
| Source: | BMC Neurology. 5/6/2025, Vol. 25 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14712377 |
|---|---|
| DOI: | 10.1186/s12883-025-04087-7 |
